Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Healthcare Medical Devices
Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115... see more

Recent & Breaking News (NDAQ:VANI)

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Business Wire August 14, 2023

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Business Wire July 11, 2023

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Business Wire June 14, 2023

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

Business Wire May 15, 2023

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Business Wire April 4, 2023

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Business Wire March 31, 2023

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Business Wire March 21, 2023

Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Business Wire November 14, 2022

Vivani Medical to Present at the ThinkEquity Investor Conference

Business Wire October 17, 2022

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

Business Wire August 31, 2022

Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.

Business Wire August 30, 2022

Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting

Business Wire July 29, 2022

Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

Business Wire July 18, 2022

Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®

Business Wire April 14, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates ECOL, ZWS, MGI, TLMD, EYES

PR Newswire February 21, 2022

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Second Sight Medical Products, Inc. Merger

Newsfile February 18, 2022

SECOND SIGHT MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Second Sight Medical Products, Inc. - EYES

PR Newswire February 16, 2022

Moore Kuehn Encourages BDSI, ZWS, EYES, and GIIX Investors to Contact Law Firm

PR Newswire February 15, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates ECOL, EYES, ZGNX, FLMN

PR Newswire February 14, 2022

Equity Alert - The M&A Class Action Firm is Investigating the Merger - SAVE, ECOL, EYES, VHAQ, BREZ, AKIC

PR Newswire February 12, 2022